**Core Concept**
Acute promyelocytic leukemia (APL), also known as AML-M3, is a subtype of acute myeloid leukemia (AML) characterized by a specific genetic abnormality and distinct clinical presentation. It is associated with a translocation between chromosomes 15 and 17, resulting in the formation of the PML-RARα fusion gene.

**Why the Correct Answer is Right**
The PML-RARα fusion gene plays a crucial role in the pathogenesis of APL by disrupting normal cell differentiation and apoptosis. The abnormal promyelocytes accumulate in the bone marrow, leading to cytopenias and bleeding complications. The presence of blast cells in the peripheral blood is a hallmark of APL, and the disease often presents with coagulopathy, as seen in this patient with petechiae and nose bleeds. The abnormal blood count, including low hemoglobin, WBCs, and platelets, further supports the diagnosis of AML-M3.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because APL is not typically associated with a deletion of chromosome 7. While deletions of chromosome 7 are common in other subtypes of AML, they are not characteristic of APL.

**Option B:** This option is incorrect because APL is not typically associated with a mutation in the NPM1 gene. Mutations in the NPM1 gene are more commonly seen in other subtypes of AML, such as AML with normal cytogenetics.

**Option C:** This option is incorrect because APL is not typically associated with a t(8;21) translocation. This translocation is more commonly seen in AML with a favorable prognosis.

**Option D:** This option is incorrect because APL is not typically associated with a deletion of the long arm of chromosome 5. While deletions of the long arm of chromosome 5 are common in other subtypes of AML, they are not characteristic of APL.

**Clinical Pearl / High-Yield Fact**
The presence of coagulopathy in a patient with AML should raise suspicion for APL, particularly if there are blast cells in the peripheral blood. APL is a distinct subtype of AML that requires prompt recognition and treatment to prevent bleeding complications and improve outcomes.

**Correct Answer:** C.